The primary insurance information will be placed in _______ of the CMS-1500 form for secondary billing
A) ?Block 9
B) the ?[Reserved for NUCC use] block
C) the FECA number block
D) the resubmission code block
A
Health Professions
You might also like to view...
Which of the following conditions does the genetically engineered drug Pulmozyme treat?
A) Diabetes B) Gaucher's disease C) Genital warts D) Cystic fibrosis
Health Professions
Pharmaceutical compounding differs from the traditional practice of pharmacy in the sense that it involves a special relationship between the patient, ________, and pharmacist
A) drug manufacturer B) insurance company C) prescriber D) nurse
Health Professions